Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Antiviral Research|December 2, 1998
Summary of the II International Symposium on CytomegalovirusM D de Jong, G J Galasso, B Gazzard, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1996
Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assayC A Boucher, W Keulen, T van Bommel, et al.
The Journal of Infectious Diseases|October 1, 1996
Changes in cellular virus load and zidovudine resistance of syncytium-inducing and non-syncytium-inducing human immunodeficiency virus populations under zidovudine pressure: a clonal analysisA B van 't Wout, M D de Jong, N A Kootstra, et al.
AIDS (London, England)|September 26, 1997
Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatmentM D de Jong, R J de Boer, F de Wolf, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 16, 2014
Preparedness for admission of patients with suspected Ebola virus disease in European hospitals: a survey, August-September 2014M D de Jong, C Reusken, P Horby, et al.
Applied and Environmental Microbiology|October 31, 2000
Introduction of an N-glycosylation site increases secretion of heterologous proteins in yeastsC M Sagt, B Kleizen, R Verwaal, et al.
Journal of Comparative Pathology|August 15, 2016
Companion Animals as a Source of Viruses for Human Beings and Food Production AnimalsL A Reperant, I H Brown, O L Haenen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2020
Sensitivity of C-Reactive Protein and Procalcitonin Measured by Point-of-Care Tests to Diagnose Urinary Tract Infections in Nursing Home Residents: A Cross-Sectional StudyS D Kuil, S Hidad, J C Fischer, et al.
The Journal of Infectious Diseases|June 1, 1994
Alternating nevirapine and zidovudine treatment of human immunodeficiency virus type 1-infected persons does not prolong nevirapine activityM D de Jong, M Loewenthal, C A Boucher, et al.
The Journal of Antimicrobial Chemotherapy|August 2, 2021
Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patientsC J Hodiamont, N P Juffermans, S E Berends, et al.
Pageof 6